Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (GB:0A2V)
LSE:0A2V
Holding GB:0A2V?
Track your performance easily
0A2V Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$45.00 - $58.92
Previous Close$49.2
Volume2.20K
Average Volume (3M)24.32K
Market Cap
$122.99B
Enterprise Value$133.08B
Total Cash (Recent Filing)€8.71B
Total Debt (Recent Filing)€18.15B
Price to Earnings (P/E)27.0
Beta0.66
Next Earnings
Jan 30, 2025EPS Estimate
$0.78Last Dividend Ex-Date
May 09, 2024Dividend Yield3%
Share Statistics
EPS (TTM)1.82
Shares Outstanding2,529,599,938
10 Day Avg. Volume1,422
30 Day Avg. Volume24,318
Standard Deviation0.06
R-Squared0.06
Alpha0.00357
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.70
Price to Sales (P/S)2.60
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$65.00Price Target Upside32.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Sanofi News
Bulls Say, Bears Say
Bulls Say
Financial HealthHealthy balance sheet with strong operating cash flow.
Market LeadershipSanofi is the leader in global generic drugs industry, especially in chemical generic drugs.
Product ExpansionDupixent indication expansion will continue to drive revenues moving forward.
Bears Say
CompetitionSales performance is likely to be impacted by competition from generic drug makers.
EarningsRevenue and earnings failed to meet expectations.
Regulatory ChallengesA U.S. filing for CSU was met with a CRL from the FDA requesting additional efficacy data.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.87% Mutual Funds
0.02% Other Institutional Investors
95.90% Public Companies and
Individual Investors
0A2V FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest share price was $45.00 and its highest was $58.92 in the past 12 months.
What is Sanofi’s market cap?
Currently, no data Available
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Jan 30, 2025 which is in 21 days.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Oct 25, 2024. The company reported $1.549 earnings per share for the quarter, beating the consensus estimate of $1.354 by $0.195.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of $1.478 which represents an annual dividend yield of 3%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is $0.78.
How many shares outstanding does Sanofi have?
Sanofi has 2,526,245,400 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of $1.549 in its last earnings report, beating expectations of $1.354. Following the earnings report the stock price went up 2.866%.
Which hedge fund is a major shareholder of Sanofi?
Among the largest hedge funds holding Sanofi’s share is Dodge & Cox. It holds Sanofi’s shares valued at 4B.
---
Sanofi Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$65.00 (32.13% Upside)
$65.00 (32.13% Upside)
Blogger Sentiment
Bullish
GB:0A2V Sentiment 90%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.34%
12-Months-Change
Fundamentals
Return on Equity
5.80%
Trailing 12-Months
Asset Growth
1.69%
Trailing 12-Months
Company Description
Sanofi
Founded in 1973, Sanofi is a France-based leading global healthcare company, which provides therapeutic solutions worldwide. It operates through business units including Pharmaceuticals (comprised of General Medicines and Speciality Care), Consumer Healthcare, and Vaccines.
---
0A2V Company Deck
---
0A2V Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Sanofi reported a solid Q3 performance with strong sales growth across its main segments, driven by successful product launches and robust pipeline developments. Financial metrics improved significantly, with an increase in gross margin and business EPS. However, challenges such as the loss of exclusivity for Aubagio and the potential impacts of the Inflation Reduction Act present headwinds. Overall, the positive aspects and growth outlook outweigh the challenges.Read More>---
0A2V Stock 12 Month Forecast
Average Price Target
$65.00
▲(32.13% Upside)
Technical Analysis
Best Analysts Covering 0A2V
1 Year
1 Year Success Rate
6/8 ratings generated profit
1 Year Average Return
+1.13%
reiterated a buy rating last month
Copying Luisa Hector's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +1.13% per trade.
---